Facial volume augmentation in 2014: overview of different filler options.

Journal of drugs in dermatology : JDD 2013 Vol.12(12) p. 1339-44

Luebberding S, Alexiades-Armenakas M

관련 도메인

Abstract

Volume loss is considered to be one of the major contributors to facial aging. Therefore, the restoration of facial volume and contour changes has become an important treatment approach in aesthetic dermatology in recent years. In October 2013 the FDA approved for the first time ever an injectable dermal filler for the augmentation of age-related volume loss. This low-molecular-weight (LMW) 20 mg/ml hyaluronic acid (HA) filler competes on the market with poly-L-lactic acid (PLLA) and calcium hydroxylapatite (CaHA), that have been used off-label for many years to restore age-related volume loss. The safety profile and efficacy of all three injectables has been intensively evaluated in innumerous clinical studies. However, each volume filler has its benefits and disadvantages, including usage, method of action and duration of effect that are reviewed in this article.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 filler 필러 주입술 dict 3
시술 dermal filler 필러 주입술 dict 1
재료 hyaluronic acid 히알루론산 dict 1
재료 calcium hydroxylapatite 칼슘하이드록시아파타이트 dict 1
재료 ha 히알루론산 dict 1
재료 caha 칼슘하이드록시아파타이트 dict 1
재료 poly-l-lactic acid 폴리락트산 dict 1
재료 plla 폴리락트산 dict 1

MeSH Terms

Aging; Cosmetic Techniques; Durapatite; Face; Humans; Hyaluronic Acid; Injections; Lactic Acid; Off-Label Use; Polyesters; Polymers; Skin Aging; United States; United States Food and Drug Administration

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문